Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-07

Clinical Trial Update: The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the Compound Herbal Formula (RHD-1) in HBV carriers with abnormal liver function has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Compound Herbal Formula (RHD-1)

Snippet

Sponsor: Taipei City Hospital | Conditions: Liver Dysfunction | Phase 3 | Status: COMPLETED